Evolent Health (NYSE: EVH) reported Q3 EPS of $0.62, $0.50 better than the analyst estimate of $0.12. Revenue for the quarter came in at $352.6 million versus the consensus estimate of $357.32 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.